David Francisco Organogenesis Holdings Inc. (ORGO) insider trading activity

David Francisco is Chief Financial Officer of Organogenesis Holdings Inc.. Currently has a direct ownership of 559,095 shares of ORGO, which is worth approximately $2.94 Million. The most recent transaction as insider was on Feb 19, 2025, when has been sold 165,156 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 559K

30.33% 3M change

30.33% 12M change

Total Value Held $2.94 Million

David Francisco Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 19 2025	BUY Grant, award, or other acquisition	-	165,156 Added 22.8%	559,095 Class A Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$2,974 $3.7 p/Share	804 Reduced 0.2%	393,939 Class A Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$126,736 $3.7 p/Share	34,253 Reduced 7.98%	394,743 Class A Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	160,350 Added 27.21%	428,996 Class A Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$2,797 $3.48 p/Share	804 Reduced 0.3%	268,646 Class A Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$82,722 $3.68 p/Share	22,479 Reduced 7.7%	269,450 Class A Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	242,508 Added 45.38%	291,929 Class A Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$2,620 $2.75 p/Share	953 Reduced 1.89%	49,421 Class A Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$10,237 $2.92 p/Share	3,506 Reduced 6.51%	50,374 Class A Common Stock
Feb 16 2022	SELL Payment of exercise price or tax liability	$7,414 $7.78 p/Share	953 Reduced 1.74%	53,880 Class A Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$15,064 $8.03 p/Share	1,876 Reduced 3.31%	54,833 Class A Common Stock
Feb 15 2022	BUY Grant, award, or other acquisition	-	40,348 Added 41.57%	56,709 Class A Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	10,965 Added 40.13%	16,361 Class A Common Stock
Feb 15 2021	BUY Grant, award, or other acquisition	-	5,396 Added 50.0%	5,396 Class A Common Stock

David Francisco

Chief Financial Officer

Canton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORGO shares.

Notify only if

Value

Insider Trading

Get notified when an Organogenesis Holdings Inc. insider buys or sells ORGO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Organogenesis Holdings Inc.

Track Activities on ORGO

Account